Translating Human Prototype Liver Implant Technology from Academia to Industry for Third-Party Transplant and In Vivo Validation
Cells · 15.05.2026 · 15 (10) · 905
DOI: 10.3390/cells15100905 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 15.05.2026. Verfasst von Dagmara Szkolnicka und 8 weiteren Autor:innen. Beteiligte Einrichtung: BioInnovation Institute, Ole Maaløes Vej 3, 3, 2200 Copenhagen, Denmark. Hauptthemen laut MEDLINE: Liver, Liver Transplantation, Translational Research, Biomedical. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BioInnovation Institute, Innovation Fund Denmark, Export and Investment Fund of Denmark.
Abstract (Originalsprache)
Annually, there are more than two million deaths from liver disease. This is driven by organ inflammation and scarring, leading to a decline in function and regeneration. Frequently, this can develop into decompensated liver disease, resulting in the loss of physiological balance and toxin build-up within the body, with an increased risk of patient mortality. Currently, there are no approved medicines for the long-term treatment of liver cirrhosis. The only successful treatment option for end-stage liver disease patients is donor organ transplantation. However, patient requirement outstrips the number of donated organs. To address this bottleneck, researchers around the world have developed cell-based prototype systems to restore failing liver function, with some in clinical trials. Although significant progress has been made, no mainstream commercial liver assist products are available for routine clinical use. In this study we developed a stem cell-derived vascularized liver tissue implant prototype from pluripotent cells. The liver tissue was produced from a stem cell line that is banked at clinical grade, and displayed stable and mature liver function over a 6-week period in vitro. This included decreasing levels of the fetal marker, alpha-fetoprotein, when the serum albumin increased. This was further supported by stable alpha-1-antitrypsin secretion and cytochrome P450 function. Following the establishment of stable liver tissue, it was delivered as a cell product or attached to an electrospun polycaprolactone scaffold, to form a tissue implant. Next, cellular material was quality-controlled, and subsequently shipped to a contract research organization for external in vivo validation. The transplanted liver tissue functioned when implanted into the kidney capsule and subcutaneously, remaining functional for up to two weeks in vivo.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- BioInnovation Institute, Ole Maaløes Vej 3, 3, 2200 Copenhagen, Denmark.
- Novo Nordisk Ltd., Novo Nordisk Park 1, 2760 Malov, Denmark.
- Centre for Regenerative Medicine, Institute of Regeneration and Repair, College of Medicine and Veterinary Medicine, The University of Edinburgh, Edinburgh EH16 4UU, UK.
ORCID-Profile: Dagmara Szkolnicka, Lydia González Del Barrio, David C Hay
Förderung
- BioInnovation Institute
- Innovation Fund Denmark
- Export and Investment Fund of Denmark
- Old College Capital
- Novo Nordisk Foundation
Zitieren
APA
Szkolnicka, D., González Del Barrio, L., Calderón, C. D. Q., Kowal, J. M., Sampath, S., Dudley, G., Sørensen, J., Karlsen, A. E., & Hay, D. C. (2026). Translating Human Prototype Liver Implant Technology from Academia to Industry for Third-Party Transplant and In Vivo Validation. Cells, 15(10), 905. https://doi.org/10.3390/cells15100905
Vancouver
Szkolnicka D, González Del Barrio L, Calderón CDQ, Kowal JM, Sampath S, Dudley G, et al. Translating Human Prototype Liver Implant Technology from Academia to Industry for Third-Party Transplant and In Vivo Validation. Cells. 2026;15(10):905. doi:10.3390/cells15100905
BibTeX
@article{Szkolnicka2026,
author = {Szkolnicka, Dagmara and González Del Barrio, Lydia and Calderón, Carlos D Quintana and Kowal, Justyna M and Sampath, Shruthi and Dudley, Giles and Sørensen, Joakim and Karlsen, Allan E and Hay, David C},
title = {Translating Human Prototype Liver Implant Technology from Academia to Industry for Third-Party Transplant and In Vivo Validation},
journal = {Cells},
year = {2026},
volume = {15},
number = {10},
pages = {905},
doi = {10.3390/cells15100905}
}
EUVIMED